You are here:

risperidone 3mg 4mg orodispersible tablets (Risperdal Quicklet)

Advice

Following an abbreviated submission

risperidone 3mg, 4mg orodispersible tablets (Risperdal Quicklet®) are accepted for restricted use within NHS Scotland for treatment of acute and chronic schizophrenia and similar psychosis and treatment of mania in bipolar disorder.

These new strengths of risperidone orodispersible tablets should be used in patients for whom risperidone is an appropriate choice of antipsychotic and an orodispersible tablet is an appropriate formulation.

Drug Details

Drug Name: risperidone 3mg 4mg orodispersible tablets (Risperdal Quicklet)
SMC Drug ID: 403/07
Manufacturer: Janssen-Cilag Ltd
Indication: for treatment of acute and chronic schizophrenia and similar psychosis and treatment of mania in bipolar disorder
BNF Category:
Sub Category: 4.2 Drugs used in psychoses and related disorders
Submission Type: Abbreviated Submission
Status: Restricted
Date Advice Published: 10 September 2007

Back